检索结果 - Alice T. Shaw

Refine Results
  1. 1
    <i>ALK</i> in Lung Cancer: Past, Present, and Future

    <i>ALK</i> in Lung Cancer: Past, Present, and Future 由 Alice T. Shaw, Jeffrey A. Engelman

    出版 2013
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  2. 2
    Novel Targets in Non-Small Cell Lung Cancer: <i>ROS1</i> and <i>RET</i> Fusions

    Novel Targets in Non-Small Cell Lung Cancer: <i>ROS1</i> and <i>RET</i> Fusions 由 Justin F. Gainor, Alice T. Shaw

    出版 2013
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  3. 3
    Molecular Pathways: Resistance to Kinase Inhibitors and Implications for Therapeutic Strategies

    Molecular Pathways: Resistance to Kinase Inhibitors and Implications for Therapeutic Strategies 由 Christine M. Lovly, Alice T. Shaw

    出版 2014
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  4. 4
    Emerging Paradigms in the Development of Resistance to Tyrosine Kinase Inhibitors in Lung Cancer

    Emerging Paradigms in the Development of Resistance to Tyrosine Kinase Inhibitors in Lung Cancer 由 Justin F. Gainor, Alice T. Shaw

    出版 2013
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  5. 5
    Resisting Resistance: Targeted Therapies in Lung Cancer

    Resisting Resistance: Targeted Therapies in Lung Cancer 由 W. Marston Linehan, Alice T. Shaw

    出版 2016
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  6. 6
    Crizotinib resistance: implications for therapeutic strategies

    Crizotinib resistance: implications for therapeutic strategies 由 Ibiayi Dagogo‐Jack, Alice T. Shaw

    出版 2016
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  7. 7
    Recent Advances in Targeting ROS1 in Lung Cancer

    Recent Advances in Targeting ROS1 in Lung Cancer 由 W. Marston Linehan, Alice T. Shaw

    出版 2017
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  8. 8
    Therapeutic Targeting of Anaplastic Lymphoma Kinase in Lung Cancer: A Paradigm for Precision Cancer Medicine

    Therapeutic Targeting of Anaplastic Lymphoma Kinase in Lung Cancer: A Paradigm for Precision Cancer Medicine 由 Ryohei Katayama, Christine M. Lovly, Alice T. Shaw

    出版 2015
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  9. 9
    Targeting ALK: Precision Medicine Takes on Drug Resistance

    Targeting ALK: Precision Medicine Takes on Drug Resistance 由 W. Marston Linehan, Gregory J. Riely, Alice T. Shaw

    出版 2017
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  10. 10
    Tyrosine kinase gene rearrangements in epithelial malignancies

    Tyrosine kinase gene rearrangements in epithelial malignancies 由 Alice T. Shaw, Peggy P. Hsu, Mark M. Awad, Jeffrey A. Engelman

    出版 2013
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  11. 11
    The Central Nervous System as a Sanctuary Site in ALK-Positive Non–Small-Cell Lung Cancer

    The Central Nervous System as a Sanctuary Site in ALK-Positive Non–Small-Cell Lung Cancer 由 Justin F. Gainor, Sai‐Hong Ignatius Ou, Jennifer Logan, Lawrence F. Borges, Alice T. Shaw

    出版 2013
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Integration of Stereotactic Body Radiation Therapy With Tyrosine Kinase Inhibitors in Stage IV Oncogene-Driven Lung Cancer

    Integration of Stereotactic Body Radiation Therapy With Tyrosine Kinase Inhibitors in Stage IV Oncogene-Driven Lung Cancer 由 Meghan Campo, H. Al-Halabi, Melin J. Khandekar, Alice T. Shaw, Lecia V. Sequist, Henning Willers

    出版 2016
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  13. 13
    Clinical Management of Adverse Events Associated with Lorlatinib

    Clinical Management of Adverse Events Associated with Lorlatinib 由 Todd M. Bauer, Enriqueta Felip, Benjamin Solomon, Holger Thurm, Gerson Peltz, Marc Chioda, Alice T. Shaw

    出版 2019
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    Cabozantinib Overcomes Crizotinib Resistance in ROS1 Fusion–Positive Cancer

    Cabozantinib Overcomes Crizotinib Resistance in ROS1 Fusion–Positive Cancer 由 Ryohei Katayama, Yuka Kobayashi, Luc Friboulet, Elizabeth L. Lockerman, Sumie Koike, Alice T. Shaw, Jeffrey A. Engelman, Naoya Fujita

    出版 2014
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    Osimertinib Responses After Disease Progression in Patients Who Had Been Receiving Rociletinib

    Osimertinib Responses After Disease Progression in Patients Who Had Been Receiving Rociletinib 由 Lecia V. Sequist, Zofia Piotrowska, Matthew J. Niederst, Rebecca S. Heist, Subba R. Digumarthy, Alice T. Shaw, Jeffrey A. Engelman

    出版 2015
    获取全文 获取全文
    Carta
    加到收藏夹
    Saved in:
  16. 16
    Alectinib Dose Escalation Reinduces Central Nervous System Responses in Patients with Anaplastic Lymphoma Kinase–Positive Non–Small Cell Lung Cancer Relapsing on Standard Dose Alectinib

    Alectinib Dose Escalation Reinduces Central Nervous System Responses in Patients with Anaplastic Lymphoma Kinase–Positive Non–Small Cell Lung Cancer Relapsing on Standard Dose Alec... 由 Justin F. Gainor, S. Andrew, Jennifer Logan, Ranliang Hu, Kevin Oh, Priscilla K. Brastianos, Helen A. Shih, Alice T. Shaw

    出版 2015
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  17. 17
    Nutrient intakes during pregnancy: observations on the influence of smoking and social class

    Nutrient intakes during pregnancy: observations on the influence of smoking and social class 由 F.M. Haste, OG Brooke, H R Anderson, J Martin Bland, Alice T. Shaw, Jane C. Griffin, Janet L. Peacock

    出版 1990
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  18. 18
    Alectinib Salvages CNS Relapses in ALK-Positive Lung Cancer Patients Previously Treated with Crizotinib and Ceritinib

    Alectinib Salvages CNS Relapses in ALK-Positive Lung Cancer Patients Previously Treated with Crizotinib and Ceritinib 由 Justin F. Gainor, Carol A. Sherman, Kathryn Willoughby, Jennifer Logan, Elizabeth A. Kennedy, Priscilla K. Brastianos, S. Andrew, Alice T. Shaw

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  19. 19
    Emergence of a RET V804M Gatekeeper Mutation During Treatment With Vandetanib in RET-Rearranged NSCLC

    Emergence of a RET V804M Gatekeeper Mutation During Treatment With Vandetanib in RET-Rearranged NSCLC 由 Ibiayi Dagogo‐Jack, Sara E. Stevens, W. Marston Linehan, Rebecca J. Nagy, Lorin A. Ferris, Alice T. Shaw, Justin F. Gainor

    出版 2018
    获取全文 获取全文
    Carta
    加到收藏夹
    Saved in:
  20. 20
    ALK Mutation Status Before and After Alectinib Treatment in Locally Advanced or Metastatic ALK-Positive NSCLC: Pooled Analysis of Two Prospective Trials

    ALK Mutation Status Before and After Alectinib Treatment in Locally Advanced or Metastatic ALK-Positive NSCLC: Pooled Analysis of Two Prospective Trials 由 Johannes Noé, Alex Lovejoy, Sai‐Hong Ignatius Ou, Stephanie J. Yaung, Walter Bordogna, Daniel M. Klass, Craig Cummings, Alice T. Shaw

    出版 2019
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: